TCS, HDFCBANK, SBI Liquid Fund (G)
Alkem Laboratories Ltd.
Alkem Laboratories
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 25 05 2021 | Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve (i) to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2021; and (ii) to consider and recommend Final Dividend, if any, for the financial year ended 31st March, 2021. Kindly take note of the same. |
| 06 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 04 02 2022 | Interim Dividend & Quarterly Results |
| 13 05 2022 | Audited Results & Final Dividend |
| 05 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 10 02 2023 | Quarterly Results & Interim Dividend |
| 19 05 2023 | Final Dividend & Audited Results |
| 10 08 2023 | Quarterly Results |
| 07 11 2023 | Quarterly Results |
| 09 02 2024 | Interim Dividend & Quarterly Results |
| 13 11 2024 | Quarterly Results |
| 07 02 2025 | Quarterly Results & Interim Dividend |
News
No News data available
